|Bid||9.66 x 900|
|Ask||9.80 x 800|
|Day's Range||9.65 - 9.75|
|52 Week Range||9.58 - 10.97|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Investment company Westchester Capital Funds (Current Portfolio) buys Far Peak Acquisition Corp, Far Peak Acquisition Corp, Reinvent Technology Partners Y, Kensington Capital Acquisition Corp V, Isos Acquisition Corp, sells , Far Peak Acquisition Corp, Far Peak Acquisition Corp, Reinvent Technology Partners Y, Reinvent Technology Partners Y during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Westchester Capital Funds.
Khosla and Boston-based Valo Health gave “current market conditions, particularly in the biotechnology area,” as the reason for calling off the deal, which was announced in June.
Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process and Khosla Ventures Acquisition Co. (Nasdaq: KVSA) ("KVSA"), a special purpose acquisition company sponsored by affiliates of Khosla Ventures, LLC, announced today that both companies have mutually agreed to terminate their previously announced agreement and plan of merger (the "Business Combination Agreement"), ef